34 Results for "

RON

" in MedChemExpress (MCE) Product Catalog:
Products (34)

34 Results for "RON" in MCE Product Catalog:

14
14 Publications Verification
Cat. No.: HY-10200
CAS No.: 1001350-96-4
Purity:  99.42%
Target:  

IGF-1R Insulin Receptor

Research Areas:  

Endocrinology Cancer

BMS-754807 is a potent and reversible IGF-1R/IR inhibitor (IC50=1.8 and 1.7 nM, respectively; Ki=<2 nM for both). BMS-754807 also shows potent activities against Met, RON, TrkA, TrkB, AurA, and AurB with IC50 values of 6, 44, 7, 4, 9, and 25 nM, respectively .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-12076
CAS No.: 1025720-94-8
Purity:  99.36%
Synonyms: BMS 817378
Target:  

c-Met/HGFR TAM Receptor

Research Areas:  

Cancer

BMS 777607 (BMS 817378) is a Met-related inhibitor for c-Met, Axl, Ron and Tyro3 with IC50s of 3.9 nM, 1.1 nM, 1.8 nM and 4.3 nM, respectively, and 40-fold more selective for Met-related targets than Lck, VEGFR-2, and TrkA/B, with more than 500-fold greater selectivity versus all other receptor and non receptor kinases .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-13299
CAS No.: 1001917-37-8
Purity:  98.34%
Target:  

c-Met/HGFR

Research Areas:  

Cancer

MK-8033 is an orally active ATP competitive c-Met/Ron dual inhibitor (IC50s: 1 nM (c-Met),7 nM (Ron)), with preferential binding to the activated kinase conformation. MK-8033 can be used in the research of cancers, such as breast and bladder cancers, non-small cell lung cancers (NSCLCs) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-13299A
CAS No.: 1283000-43-0
Purity:  99.86%
Target:  

c-Met/HGFR

Research Areas:  

Cancer

MK-8033 hydrochloride is an orally active ATP competitive c-Met/Ron dual inhibitor (IC50s: 1 nM (c-Met),7 nM (Ron)), with preferential binding to the activated kinase conformation. MK-8033 hydrochloride can be used in the research of cancers, such as breast and bladder cancers, non-small cell lung cancers (NSCLCs) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-116000
CAS No.: 1642581-63-2
Purity:  99.94%
Synonyms: GumaRONtinib; SCC244
Target:  

c-Met/HGFR

Research Areas:  

Cancer

Glumetinib (SCC244) is a highly selective, orally bioavailable, ATP-competitive c-Met inhibitor with an IC50 of 0.42 nM. Glumetinib has greater than 2400-fold selectivity for c-Met over those 312 kinases evaluated, including the c-Met family member RON and highly homologous kinases Axl, Mer, TyrO3. Antitumor activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12035
CAS No.: 1002304-34-8
Purity:  99.86%
Research Areas:  

Cancer

AMG-208 is an orally active c-Met/RON dual selective inhibitor with an IC50 of 9 nM for c-Met. AMG-208 is a CYP3A4 inhibitor with an IC50 of 32 μM. AMG-208 has anti-cancer activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-50703
CAS No.: 917879-39-1
Target:  

c-Met/HGFR

Research Areas:  

Cancer

MK-2461 is an ATP-competitive, selective and orally active wild-type and mutant c-Met inhibitor (IC50s: 0.4-2.5 nM). MK-2461 also inhibits Ron (IC50 of 7 nM) and Flt1 (IC50 of 10 nM), MK-2461 shows selective for c-MET over other kinases (lC50s = 22-7800 nM). MK-2461 can be used for the study of cancer, such as gastric cancer .
loading...
    loading...
Cat. No.: HY-P99375
CAS No.: 1188275-92-4
Synonyms: IMC-RON8; LY3012219; Anti-MSPR/RON/CD136 Reference Antibody (narnatumab)

Target:  

Tyrosinase c-Met/HGFR

Research Areas:  

Cancer

Narnatumab (IMC-RON8) is a neutralizing human monoclonal antibody that blocks RON binding to its ligand, macrophage-stimulating protein (MSP), with a Kd of 32 pM. Narnatumab can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-18307
CAS No.: 913376-84-8
Target:  

c-Met/HGFR

Research Areas:  

Cancer

SYN1143 is a potent, selective and orally active dual inhibitor of c-Met/RON, with IC50s of 4 and 9 nM, respectively. SYN1143 has weak inhibitory activity on Lck, Tie2, Src, and BTK with IC50s ranging from 160 to 710 nM. SYN1143 can be used for the research of cancers that RON and c-Met are activated .
loading...
    loading...
Cat. No.: HY-126425
CAS No.: 344359-25-7
Purity:  99.22%
Target:  

Parasite

Research Areas:  

Infection

NCGC00262650 is a potent apical membrane antigen 1-rhoptry neck protein 2 (AMA1-RON2) interaction inhibitor. NCGC00262650 can block entry of merozoites into red blood cells with an IC50 of 9.8 μM .
loading...
    loading...
Cat. No.: HY-123262
CAS No.: 669764-17-4
Target:  

c-Met/HGFR VEGFR

Research Areas:  

Cancer

SU11606 is a Met inhibitor, with an average IC50 of 0.17 μM. SU11606 shows inhibitory activity on Ron, FLK-1, with IC50s of 2.5 μM and 0.18 μM, respectively. SU11606 can be used in the research of tumors .
loading...
    loading...
Cat. No.: HY-P990471

Target:  

Tyrosinase

Research Areas:  

Inflammation/Immunology

The Anti-MSPR/RON/CD136 Antibody is a human antibody expressed in CHO, targeting MSPR/RON/CD136. The Anti-MSPR/RON/CD136 Antibody is equipped with huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 145.74 kDa. The isotype control for the Anti-MSPR/RON/CD136 Antibody can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-P990472
Synonyms: H5B14

Target:  

c-Met/HGFR

Research Areas:  

Inflammation/Immunology

Anti-MSPR/RON/CD136 Antibody (H5B14) is a humanized antibody expressed in CHO cells, targeting MSPR/RON/CD136. Anti-MSPR/RON/CD136 Antibody (H5B14) has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 156.7 kDa. The isotype control for Anti-MSPR/RON/CD136 Antibody (H5B14) can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-155812
CAS No.: 2377507-01-0
Target:  

c-Met/HGFR

Research Areas:  

Cancer

Tyrosine kinase-IN-6 is a potent and promising RON splice variants inhibitor with anti-cancer and o?antineoplastic effects .
loading...
    loading...
Cat. No.: HY-118269
CAS No.: 1175296-94-2
Target:  

c-Met/HGFR

Research Areas:  

Cancer

OSI-296 is a potent, oral and selective inhibitor of cMET and RON kinases. OSI-296 shows in vivo efficacy in MKN45 tumor xenografts models and well tolerated .
loading...
    loading...
Cat. No.: HY-123225
CAS No.: 1229611-73-7
Target:  

c-Met/HGFR

Research Areas:  

Cancer

LCRF-0004 is a potent inhibitor of RON kinase, with the IC50 value of 10 nM. and a surprising result is also obtained regarding its c-Met inhibitory activity, with the IC50 value of 12 nM. LCRF-0004 plays an important role in cancer research .
loading...
    loading...
Cat. No.: HY-RS08730
Research Areas:  

Others

MST1R Human Pre-designed siRNA Set A contains three designed siRNAs for MST1R gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS18291
Research Areas:  

Others

Mst1r Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mst1r gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-162085
CAS No.: 3048409-80-6
Target:  

TAM Receptor

Research Areas:  

Cancer

Axl-IN-17 (compound 13c) is an orally active, selective AXL inhibitor with an IC50 value of 3.2 nM. Axl-IN-17 reveals antitumor efficacy .
loading...
    loading...
Cat. No.: HY-123237
CAS No.: 1146944-35-5
Research Areas:  

Cancer

KRC-108, an aminopyridine, is an orally active multiple kinase inhibitor with IC50s of 80 nM, 23 nM, 3 nM, 70 nM, 30 nM, 39 nM for c-Met, c-Met M1250T, c-Met Y1230D, Ron, Flt3 and TrkA, respectively. KRC-108 induces cell cycle arrest, apoptotic cell death, and autophagy. KRC-108 exhibits anti-tumor activity in vivo in HT29 colorectal cancer, NCI-H441 lung cancer xenograft models in athymic BALB/c nu/nu mice .
loading...
    loading...